Helicobacter pylori infection and colorectal carcinoma: Is there a causal association?

Journal of Gastrointestinal Oncology

Volumn 3, Issue 4, 2012, Pages 380-385

  Tatishchev, Sergei F ^a   VanBeek, Christine ^b   Wang, Hanlin L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GASTRIN;

BACTERIAL COLONIZATION; BACTERIAL STRAIN; CARCINOGENICITY; CHRONIC INFLAMMATION; COLON CARCINOGENESIS; COLORECTAL CARCINOMA; DIET; DISEASE ASSOCIATION; ENVIRONMENTAL FACTOR; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; HYPERGASTRINEMIA; INTESTINE FLORA; LETTER; LIFESTYLE; NONHUMAN; PATHOPHYSIOLOGY; STREPTOCOCCUS BOVIS;

EID: 84995745402     PISSN: 20786891     EISSN: 2219679X     Source Type: Journal    
DOI: 10.3978/j.issn.2078-6891.2012.058     Document Type: Letter

References (95)

1. Kapetanakis N, Kountouras J, Zavos C, et al. Helicobacter pylori infection and colorectal carcinoma: pathologic aspects. J Gastrointest Oncol 2012. [Epub ahead of print].
2. Fleming M, Ravula S, Tatishchev SF, et al. Colorectal carcinoma: Pathologic aspects. J Gastrointest Oncol 2012;3:153-73.
3. McCoy WC, Mason JM 3rd. Enterococcal endocarditis associated with carcinoma of the sigmoid; report of a case. J Med Assoc State Ala 1951;21:162-6.
4. Klein RS, Recco RA, Catalano MT, et al. Association of Streptococcus bovis with carcinoma of the colon. N Engl J Med 1977;297:800-2.
5. Murray HW, Roberts RB. Streptococcus bovis bacteremia and underlying gastrointestinal disease. Arch Intern Med 1978;138:1097-9.
6. Gold JS, Bayar S, Salem RR. Association of Streptococcus bovis bacteremia with colonic neoplasia and extracolonic malignancy. Arch Surg 2004;139:760-5.
7. Ellmerich S, Schöller M, Duranton B, et al. Promotion of intestinal carcinogenesis by Streptococcus bovis. Carcinogenesis 2000;21:753-6.
8. Li A, Varney ML, Singh RK. Expression of interleukin 8 and its receptors in human colon carcinoma cells with different metastatic potentials. Clin Cancer Res 2001;7:3298-304.
9. Lee YS, Choi I, Ning Y, et al. Interleukin-8 and itsreceptor CXCR2 in the tumour microenvironment promote colon cancer growth, progression and metastasis. Br J Cancer 2012;106:1833-41.
10. Fox SH, Whalen GF, Sanders MM, et al. Angiogenesis in normal tissue adjacent to colon cancer. J Surg Oncol 1998;69:230-4.
11. Brew R, Erikson JS, West DC, et al. Interleukin-8 as an autocrine growth factor for human colon carcinoma cells in vitro. Cytokine 2000;12:78-85.
12. Reddy BS, Weisburger JH, Narisawa T, et al. Colon carcinogenesis in germ-free rats with 1,2-dimethylhydrazine and N-methyl-n'-nitro-N-nitrosoguanidine. Cancer Res 1974;34:2368-72.
13. Reddy BS, Narisawa T, Wright P, et al. Colon carcinogenesis with azoxymethane and dimethylhydrazine in germ-free rats. Cancer Res 1975;35:287-90.
14. Cuevas-Ramos G, Petit CR, Marcq I, et al. Escherichia coli induces DNA damage in vivo and triggers genomic instability in mammalian cells. Proc Natl Acad Sci U S A 2010;107:11537-42.
15. Wu S, Morin PJ, Maouyo D, et al. Bacteroides fragilis enterotoxin induces c-Myc expression and cellular proliferation. Gastroenterology 2003;124:392-400.
16. Toprak NU, Yagci A, Gulluoglu BM, et al. A possible role of Bacteroides fragilis enterotoxin in the aetiology of colorectal cancer. Clin Microbiol Infect 2006;12:782-6.
17. Sears CL, Islam S, Saha A, et al. Association of enterotoxigenic Bacteroides fragilis infection with inflammatory diarrhea. Clin Infect Dis 2008;47:797-803.
18. Sobhani I, Tap J, Roudot-Thoraval F, et al. Microbial dysbiosis in colorectal cancer (CRC) patients. PLoS One 2011;6:e16393.
19. Wang X, Allen TD, May RJ, et al. Enterococcus faecalis induces aneuploidy and tetraploidy in colonic epithelial cells through a bystander effect. Cancer Res 2008;68:9909-17.
20. Moore WE, Moore LH. Intestinal floras of populations that have a high risk of colon cancer. Appl Environ Microbiol 1995;61:3202-7.
21. Sungkanuparph S, Chansirikarnjana S, Vorachit M. Eubacterium bacteremia and colon cancer. Scand J Infect Dis 2002;34:941-3.
22. Dylewski J, Luterman L. Septic arthritis and Clostridium septicum: a clue to colon cancer. CMAJ 2010;182:1446-7.
23. Selgrad M, Bornschein J, Rokkas T, et al. Helicobacter pylori: Gastric Cancer and Extragastric Intestinal Malignancies. Helicobacter 2012;17:30-5.
24. Meucci G, Tatarella M, Vecchi M, et al. High prevalence of Helicobacter pylori infection in patients with colonic adenomas and carcinomas. J Clin Gastroenterol 1997;25:605-7.
25. Aydin A, Karasu Z, Zeytinoglu A, et al. Colorectal adenomateous polyps and Helicobacter pylori infection. Am J Gastroenterol 1999;94:1121-2.
26. Fujimori S, Kishida T, Kobayashi T, et al. Helicobacter pylori infection increases the risk of colorectal adenoma and adenocarcinoma, especially in women. J Gastroenterol 2005;40:887-93.
27. Lin YL, Chiang JK, Lin SM, et al. Helicobacter pylori infection concomitant with metabolic syndrome further increase risk of colorectal adenomas. World J Gastroenterol 2010;16:3841-6.
28. Mizuno S, Morita Y, Inui T, et al. Helicobacter pylori infection is associated with colon adenomatous polyps detected by high-resolution colonoscopy. Int J Cancer 2005;117:1058-9.
29. Inoue I, Mukoubayashi C, Yoshimura N, et al. Elevated risk of colorectal adenoma with Helicobacter pylori-related chronic gastritis: a population-based case-control study. Int J Cancer 2011;129:2704-11.
30. Hong SN, Lee SM, Kim JH, et al. Helicobacter pylori infection increases the risk of colorectal adenomas: cross-sectional study and meta-analysis. Dig Dis Sci 2012;57:2184-94.
31. Zhang Y, Hoffmeister M, Weck MN, et al. Helicobacter pylori infection and colorectal cancer risk: evidence from a large population-based case-control study in Germany. Am J Epidemiol 2012;175:441-50.
32. Kapetanakis N, Kountouras J, Zavos C, et al. Re: helicobacter pylori infection and colorectal cancer risk: evidence from a large population-based case-control study in Germany. Am J Epidemiol 2012;176:566-7.
33. Moss SF, Neugut AI, Garbowski GC, et al. Helicobacter pylori seroprevalence and colorectal neoplasia: evidence against an association. J Natl Cancer Inst 1995;87:762-3.
34. Siddheshwar RK, Muhammad KB, Gray JC, et al. Seroprevalence of Helicobacter pylori in patients with colorectal polyps and colorectal carcinoma. Am J Gastroenterol 2001;96:84-8.
35. Bae RC, Jeon SW, Cho HJ, et al. Gastric dysplasia may be an independent risk factor of an advanced colorectal neoplasm. World J Gastroenterol 2009;15:5722-6.
36. Abbass K, Gul W, Beck G, et al. Association of Helicobacter pylori infection with the development of colorectal polyps and colorectal carcinoma. South Med J 2011;104:473-6.
37. Robertson DJ, Sandler RS, Ahnen DJ, et al. Gastrin, Helicobacter pylori, and colorectal adenomas. Clin Gastroenterol Hepatol 2009;7:163-7.
38. Zumkeller N, Brenner H, Zwahlen M, et al. Helicobacter pylori infection and colorectal cancer risk: a meta-analysis. Helicobacter 2006;11:75-80.
39. Zhao YS, Wang F, Chang D, et al. Meta-analysis of different test indicators: Helicobacter pylori infection and the risk of colorectal cancer. Int J Colorectal Dis 2008;23:875-82.
40. Sirinek KR, Levine BA, Moyer MP. Pentagastrin stimulates in vitro growth of normal and malignant human colon epithelial cells. Am J Surg 1985;149:35-9.
41. Watson SA, Durrant LG, Morris DL. Growth-promoting action of gastrin on human colonic and gastric tumour cells cultured in vitro. Br J Surg 1988;75:342-5.
42. Watson S, Durrant L, Morris D. Gastrin: growth enhancing effects on human gastric and colonic tumour cells. Br J Cancer 1989;59:554-8.
43. Wang TC, Koh TJ, Varro A, et al. Processing and proliferative effects of human progastrin in transgenic mice. J Clin Invest 1996;98:1918-29.
44. Wang TC, Dockray GJ. Lessons from genetically engineered animal models. I. Physiological studies with gastrin in transgenic mice. Am J Physiol 1999;277:G6-11.
45. Koh TJ, Dockray GJ, Varro A, et al. Overexpression of glycine-extended gastrin in transgenic mice results in increased colonic proliferation. J Clin Invest 1999;103:1119-26.
46. Koh TJ, Goldenring JR, Ito S, et al. Gastrin deficiency results in altered gastric differentiation and decreased colonic proliferation in mice. Gastroenterology 1997;113:1015-25.
47. Smith JP, Wood JG, Solomon TE. Elevated gastrin levels in patients with colon cancer or adenomatous polyps. Dig Dis Sci 1989;34:171-4.
48. Wong K, Beardshall K, Waters CM, et al. Postprandial hypergastrinaemia in patients with colorectal cancer. Gut 1991;32:1352-4.
49. Seitz JF, Giovannini M, Gouvernet J, et al. Elevated serum gastrin levels in patients with colorectal neoplasia. J Clin Gastroenterol 1991;13:541-5.
50. Thorburn CM, Friedman GD, Dickinson CJ, et al. Gastrin and colorectal cancer: a prospective study. Gastroenterology 1998;115:275-80.
51. Pinson DM, Havu N, Sztern MI, et al. Drug-induced hypergastrinemia: absence of trophic effects on colonic carcinoma in rats. Gastroenterology 1995;108:1068-74.
52. Hurwitz A, Sztern MI, Looney GA, et al. Effects of omeprazole on cell kinetics of carcinogen-induced colon tumours in rats. Cell Prolif 1995;28:525-31.
53. Graffner H, Singh G, Chaudry I, et al. Omeprazole-induced hypergastrinemia does not influence growth of colon carcinoma. Dig Dis Sci 1992;37:485-9.
54. Penman ID, El-Omar E, McGregor JR, et al. Omeprazole inhibits colorectal carcinogenesis induced by azoxymethane in rats. Gut 1993;34:1559-65.
55. Singh M, Dhindsa G, Friedland S, et al. Long-term use of proton pump inhibitors does not affect the frequency, growth, or histologic characteristics of colon adenomas. Aliment Pharmacol Ther 2007;26:1051-61.
56. Orbuch M, Venzon DJ, Lubensky IA, et al. Prolonged hypergastrinemia does not increase the frequency of colonic neoplasia in patients with Zollinger-Ellison syndrome. Dig Dis Sci 1996;41:604-13.
57. Lamberts R, Wartenberg T, Creutzfeldt W. Role of circulating gastrin in colorectal adenomas and carcinomas. Digestion 1999;60:101-9.
58. Suzuki H, Matsumoto K, Terashima H. Serum levels of gastrin in patients with colorectal neoplasia. Dis Colon Rectum 1988;31:716-7.
59. Penman ID, El-Omar E, Ardill JE, et al. Plasma gastrin concentrations are normal in patients with colorectal neoplasia and unaltered following tumor resection. Gastroenterology 1994;106:1263-70.
60. Kikendall JW, Glass AR, Sobin LH, et al. Serum gastrin is not higher in subjects with colonic neoplasia. Am J Gastroenterol 1992;87:1394-7.
61. Vanderstraeten EF, De Vos MM, Versieck JM, et al. Serum gastrin levels and colorectal neoplasia. Dis Colon Rectum 1995;38:172-6.
62. Baldwin GS, Zhang QX. Measurement of gastrin and transforming growth factor alpha messenger RNA levels in colonic carcinoma cell lines by quantitative polymerase chain reaction. Cancer Res 1992;52:2261-7.
63. Monges G, Biagini P, Cantaloube JF, et al. Detection of gastrin mRNA in fresh human colonic carcinomas by reverse transcription-polymerase chain reaction. J Mol Endocrinol 1993;11:223-9.
64. Finley GG, Koski RA, Melhem MF, et al. Expression of the gastrin gene in the normal human colon and colorectal adenocarcinoma. Cancer Res 1993;53:2919-26.
65. Xu Z, Dai B, Dhruva B, et al. Gastrin gene expression in human colon cancer cells measured by a simple competitive PCR method. Life Sci 1994;54:671-8.
66. Singh P, Dai B, Wu H, et al. Role of autocrine and endocrine gastrin-like peptides in colonic carcinogenesis. Curr Opin Gastroenterol 2000;16:68-77.
67. Bombski G, Gasiorowska A, Orszulak-Michalak D, et al. Elevated plasma gastrin, CEA, and CA 19-9 levels decrease after colorectal cancer resection. Int J Colorectal Dis 2003;18:148-52.
68. Charnley RM, Thomas WM, Stanley J, et al. Serum gastrin concentrations in colorectal cancer patients. Ann R Coll Surg Engl 1992;74:138-40; discussion 141.
69. Kanno T, Matsuki T, Oka M, et al. Gastric acid reduction leads to an alteration in lower intestinal microflora. Biochem Biophys Res Commun 2009;381:666-70.
70. Macfarlane GT, Macfarlane LE. Acquisition, evolution and maintenance of the normal gut microbiota. Dig Dis 2009;27:90-8.
71. Husebye E. The pathogenesis of gastrointestinal bacterial overgrowth. Chemotherapy 2005;51:1-22.
72. Batt RM, Rutgers HC, Sancak AA. Enteric bacteria: friend or foe? J Small Anim Pract 1996;37:261-7.
73. Stemmermann GN, Nomura AM, Chyou PH. Cancer incidence following subtotal gastrectomy. Gastroenterology 1991;101:711-5.
74. Bundred NJ, Whitfield BC, Stanton E, et al. Gastric surgery and the risk of subsequent colorectal cancer. Br J Surg 1985;72:618-9.
75. Toftgaard C. Risk of colorectal cancer after surgery for benign peptic ulceration. Br J Surg 1987;74:573-5.
76. Thiruvengadam R, Hench V, Melton LJ 3rd, et al. Cancer of the nongastric hollow organs of the gastrointestinal tract after gastric surgery. Arch Intern Med 1988;148:405-7.
77. Lundegårdh G, Adami HO, Helmick C, et al. The risk of large bowel cancer after partial gastrectomy for benign ulcer disease. Ann Surg 1990;212:714-9.
78. Fisher SG, Davis F, Nelson R, et al. Large bowel cancer following gastric surgery for benign disease: a cohort study. Am J Epidemiol 1994;139:684-92.
79. Parsonnet J, Friedman GD, Orentreich N, et al. Risk for gastric cancer in people with CagA positive or CagA negative Helicobacter pylori infection. Gut 1997;40:297-301.
80. Wu AH, Crabtree JE, Bernstein L, et al. Role of Helicobacter pylori CagA+ strains and risk of adenocarcinoma of the stomach and esophagus. Int J Cancer 2003;103:815-21.
81. Shmuely H, Passaro D, Figer A, et al. Relationship between Helicobacter pylori CagA status and colorectal cancer. Am J Gastroenterol 2001;96:3406-10.
82. Parente F, Imbesi V, Maconi G, et al. Influence of bacterial CagA status on gastritis, gastric function indices, and pattern of symptoms in H. pylori-positive dyspeptic patients. Am J Gastroenterol 1998;93:1073-9.
83. Konturek PC, Konturek SJ, Bielanski W, et al. Role of gastrin in gastric cancerogenesis in Helicobacter pylori infected humans. J Physiol Pharmacol 1999;50:857-73.
84. Konturek SJ, Starzynska T, Konturek PC, et al. Helicobacter pylori and CagA status, serum gastrin, interleukin-8 and gastric acid secretion in gastric cancer. Scand J Gastroenterol 2002;37:891-8.
85. Eftang LL, Esbensen Y, Tannæs TM, et al. Interleukin-8 is the single most up-regulated gene in whole genome profiling of H. pylori exposed gastric epithelial cells. BMC Microbiol 2012;12:9.
86. Kuipers EJ, Pérez-Pérez GI, Meuwissen SG, et al. Helicobacter pylori and atrophic gastritis: importance of the cagA status. J Natl Cancer Inst 1995;87:1777-80.
87. Sozzi M, Valentini M, Figura N, et al. Atrophic gastritis and intestinal metaplasia in Helicobacter pylori infection: the role of CagA status. Am J Gastroenterol 1998;93:375-9.
88. Pilotto A, Rassu M, Bozzola L, et al. Cytotoxin-associated gene A-positive Helicobacter pylori infection in the elderly. Association with gastric atrophy and intestinal metaplasia. J Clin Gastroenterol 1998;26:18-22.
89. Soylu A, Ozkara S, Alis H, et al. Immunohistochemical testing for Helicobacter Pylori existence in neoplasms of the colon. BMC Gastroenterol 2008;8:35.
90. Jones M, Helliwell P, Pritchard C, et al. Helicobacter pylori in colorectal neoplasms: is there an aetiological relationship? World J Surg Oncol 2007;5:51.
91. Grahn N, Hmani-Aifa M, Fransén K, et al. Molecular identification of Helicobacter DNA present in human colorectal adenocarcinomas by 16S rDNA PCR amplification and pyrosequencing analysis. J Med Microbiol 2005;54:1031-5.
92. Monstein HJ, Olsson C, Nilsson I, et al. Multiple displacement amplification of DNA from human colon and rectum biopsies: bacterial profiling and identification of Helicobacter pylori-DNA by means of 16S rDNA-based TTGE and pyrosequencing analysis. J Microbiol Methods 2005;63:239-47.
93. Kelly SM, Pitcher MC, Farmery SM, et al. Isolation of Helicobacter pylori from feces of patients with dyspepsia in the United Kingdom. Gastroenterology 1994;107:1671-4.
94. Kabir S. Detection of Helicobacter pylori in faeces by culture, PCR and enzyme immunoassay. J Med Microbiol 2001;50:1021-9.
95. Parsonnet J, Shmuely H, Haggerty T. Fecal and oral shedding of Helicobacter pylori from healthy infected adults. JAMA 1999;282:2240-5.